Zdrowie i gospodarka · 30/10/2015

FDA Reopens Comment Period for Minimal Manipulation Guidance

The Food and Drug Administration (FDA) is reopening the comment period for its draft guidance on minimal manipulation of human cells, tissues, and cellular and tissue-based products, allowing industry and FDA staff more time to submit comments and provide new information.